Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference5 articles.
1. The cytokine release syndrome (CRS) of severe COVID-19 and interleukin-6 receptor (IL-6R) antagonist tocilizumab may be the key to reduce the mortality;Zhang;Int J Antimicrob Agents,2020
2. Managing side effects of JAK inhibitors for myelofibrosis in clinical practice;Saeed;Expert Rev Hematol,2017
3. COVID-19: combining antiviral and anti-inflammatory treatments;Stebbing;Lancet Infect Dis,2020
4. Exploring the relevance of senotherapeutics for the current SARS-CoV-2 emergency and similar future global health threats;Malavolta;Cells,2020
5. The effect of CYP3A4 inhibition or induction on the pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 Phosphate) in healthy volunteers;Shi;J Clin Pharmacol,2012
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunosenescence and Inflammaging in COVID-19;Viral Immunology;2023-11-01
2. Inflammation inhibitory activity of green tea, soybean, and guava extracts during Sars-Cov-2 infection through TNF protein in cytokine storm;Computational Biology and Chemistry;2023-08
3. Repurposing Anti-inflammatory Agents in the Potential Treatment of SARS-COV-2 Infection;Drug Repurposing for Emerging Infectious Diseases and Cancer;2023
4. Small-molecule metabolites in SARS-CoV-2 treatment: a comprehensive review;Biological Chemistry;2022-12-09
5. Interleukin Receptor Antagonists and Janus Kinase Inhibitors Repurposed for Treatment of COVID-19;Mini-Reviews in Medicinal Chemistry;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3